SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Medizone International Inc. – ‘15-15D’ on 10/19/20

On:  Monday, 10/19/20, at 12:17pm ET   ·   Effective:  10/19/20   ·   Accession #:  1185185-20-1447   ·   File #:  333-224119

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/19/20  Medizone International Inc.       15-15D     10/19/20    1:12K                                    Federal Filings, LLC/FA

Notice of a Suspension of Duty to File Reports   —   Form 15   —   Sect. 15(d)
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 15-15D      Notice of a Suspension of Duty to File Reports      HTML      9K 


This is an HTML Document rendered as filed.  [ Alternative Formats ]



  mediintl20201015_1512g.htm  
 C:  <>  <> 

 

OMB APPROVAL

OMB Number: 3235-0167

Expires: May 31, 2021

Estimated average burden hours per response 1.50



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 15

 


 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number 333-224119

 

 

Medizone International, Inc.

(Exact name of registrant as specified in its charter)

 

2544 Route 534, Albrightsville, Pa 18210

Tel: 321-216-7500

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common Stock

(Title of each class of securities covered by this Form)

 

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1) ☐

Rule 12g-4(a)(2) ☐

Rule 12h-3(b)(1)(i) ☐

Rule 12h-3(b)(1)(ii) ☐

Rule 15d-6 ☒

 

Approximate number of holders of record as of the certification or notice date: 2247

 

Pursuant to the requirements of the Securities Exchange Act of 1934 Medizone International, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

 

Date: October 14, 2020                                        By: Angela Collette, Receiver                            

 

Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature.

 

 

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

 

Dates Referenced Herein

This ‘15-15D’ Filing    Date    Other Filings
5/31/21None on these Dates
Filed on / Effective on:10/19/20
10/14/20
 List all Filings 
Top
Filing Submission 0001185185-20-001447   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 20, 8:39:15.1am ET